SCHEMBL2117697

SCHEMBL2117697

Cc1ccc(-c2ccc(C)c(NS(=O)(=O)c3ccc(O)cc3)c2)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 2/20 0.50
POLB P06746 2/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 6/20 0.45
GAA P10253 5/20 0.45
GFER P55789 1/20 0.45
LMNA P02545 2/20 0.43
CYP2C9 P11712 2/20 0.43
GSK3B P49841 1/20 0.43
HTT P42858 2/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TRIM24 O15164 1/20 0.42
CYTH2 Q99418 1/20 0.42
UQCRB P14927 1/20 0.41
HSD17B10 Q99714 2/20 0.41
EDNRA P25101 1/20 0.40
TP53 P04637 1/20 0.40
MEN1 O00255 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117458 0.88 POLB (0.54) GHSRPOLBRAB9AALDH1A1TP53
SCHEMBL2120040 0.88 ALDH1A1 (0.47) GHSRPOLBRAB9AALDH1A1GAA
SCHEMBL2121604 0.85 POLB (0.45) GHSRPOLBRAB9AALDH1A1CYP2C9
SCHEMBL2122089 0.82 POLB (0.47) GHSRPOLBRAB9AALDH1A1GAA
SCHEMBL2119088 0.81 TRIM24 (0.60) GHSRPOLBALDH1A1GAAGFER
SCHEMBL2120014 0.81 POLB (0.51) GHSRPOLBRAB9AALDH1A1GAA
SCHEMBL2118662 0.80 ALDH1A1 (0.61) POLBALDH1A1GAAGFERLMNA
SCHEMBL2117486 0.80 POLB (0.43) GHSRPOLBRAB9AALDH1A1GAA
SCHEMBL2118302 0.79 SLC40A1 (0.47) POLBRAB9ATSHRNPSR1ALOX15
SCHEMBL2119780 0.78 KIT (0.45) GHSRPOLBRAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1AN, HIF1A, EGLN2 GHSR 2166/4885POLB 817/4885RAB9A 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.